Join the Infections group to help and get support from people like you.
Infections News (Page 4)
Arizona Health Officials Warn of Uptick in Hantavirus Cases
WEDNESDAY, July 24, 2024 – Arizona health officials are reporting an increase in hantavirus infections, which are spread by rodents and can cause severe respiratory illness. In a recent health...
Raw Milk Exposure a Real Bird Flu Risk for Humans, but Fast Spread Unlikely
WEDNESDAY, July 10, 2024 – While exposure to raw cow's milk infected with the H5N1 avian influenza virus can make you sick, a new study suggests the virus may not spread quickly to other people....
Less Than Half of American Adults Know Dangers of Raw Milk
WEDNESDAY, July 10, 2024 – Few Americans understand the health risks of drinking raw milk, a new survey shows, so experts are redoubling efforts to get the word out on its dangers. The push...
Case of Human Plague Confirmed in Colorado
WEDNESDAY, July 10, 2024 – Colorado health officials on Tuesday confirmed a case of human plague in that state. The infection – which occurred in Pueblo County, in the southern part of the state --...
Scientists Develop High-Tech 'Air Mask' to Ward Off Viruses
TUESDAY, July 10, 2024 – An experimental “air mask” could help ward off infectious diseases while people are on the job, researchers report. The mask uses an air curtain blowing down from the brim of...
FDA Approves DefenCath (taurolidine and heparin) to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
Berkeley Heights, NJ – November 15, 2023 – CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of ...
FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections
November 14, 2019 – The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary...
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza
October 24, 2018 – Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older...
FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...
FDA Approves Arikayce (amikacin liposome inhalation suspension) to treat Mycobacterium Avium Complex (MAC) Lung Disease
September 28, 2018 – The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of...
Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) – Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
Zemdri (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI)
SOUTH SAN FRANCISCO, Calif., June 26, 2018 (GLOBE NEWSWIRE) – Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug...
FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections
August 29, 2017 – The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis,...
FDA Medwatch Alert: Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial by Heritage Pharmaceuticals: Recall - Lack of Sterility Assurance
ISSUE: Heritage Pharmaceuticals Inc. announced the voluntary nationwide recall of ten (10) lots of Colistimethate for Injection, USP, 150 mg Single-Dose vial (NDC 23155-193-31) and three (3) lots of ...
Further information
Related condition support groups
Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Diseases, Viral Infection